THYROID GLAND PAPILLARY CARCINOMA
Clinical trials for THYROID GLAND PAPILLARY CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new THYROID GLAND PAPILLARY CARCINOMA trials appear
Sign up with your email to follow new studies for THYROID GLAND PAPILLARY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to shrink tough thyroid tumors before surgeons operate
Disease control OngoingThis study is testing whether a targeted pill called selpercatinib can shrink thyroid tumors before surgery. It is for people with advanced thyroid cancer that has a specific genetic change (RET alteration). The goal is to see if shrinking the tumor first makes surgery easier and…
Matched conditions: THYROID GLAND PAPILLARY CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New drug combo aims to tame tough thyroid cancers
Disease control OngoingThis study is testing whether a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—can help control advanced thyroid cancer that has stopped responding to radioactive iodine and has worsened after one prior targeted therapy. The goal is to see if this three-drug a…
Matched conditions: THYROID GLAND PAPILLARY CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC